Endoscope reprocessing involves the cleaning, disinfection, and sterilization of medical instruments and encompasses the steps of cleaning, rinsing, disinfection, secondary rinsing, drying, and storage. It is the fastest-growing segment in the disinfection technologies market due to the rising tide of cleaning standards and mounting pressure for sterilized and disinfected medical devices in hospitals and clinics.
The growing importance of diagnostic and therapeutic endoscopy procedures and the increasing number of minimally invasive surgeries across the globe are some of the key factors contributing to the growth of this market.
With the surge in the use of endoscopes, the risk of infections linked to their reprocessing is also increasing. When endoscopes are used on multiple patients, they become contaminated with microorganisms.
In order to avoid such a risk of infection, endoscopes undergo a detailed and automated multistep process to clean or sterilize them, known as reprocessing. Special care must also be taken while reprocessing endoscopes, as inadequate reprocessing can result in adverse patient outcomes such as tissue irritation from residual reprocessing materials (chemical disinfectants). It is also important that the endoscope be designed in such a way that it can be adequately reprocessed.
Reprocessing of endoscopes involves three steps:
- Initial cleaning and measures to prevent contamination of the device
- Devices are thoroughly cleaned in a dedicated cleaning area.
- The device is disinfected or sterilized and finally put back into use.
The entire endoscopy market is also expected to grow in the coming years, thus propelling the reprocessing and cleaners segment of the market. The infection control market witnessed healthy growth in the last decade owing to the rising aging population and prevalence of chronic diseases, an increase in the number of surgeries performed, and the rising occurrence of hospital-acquired infections. Though stringent regulations and saturation in developed economies will restrict the growth of the market to a certain extent,
North America accounts for the largest share of the infection control market, followed by Europe, while Asia-Pacific is an emerging market. However, Asia is expected to display favorable growth in the coming years, primarily due to a rise in awareness, the growth of an aging population, an increase in the number of surgeries, and growth in per capita income.
The global endoscope reprocessing device market is segmented on the following bases:
Based on product type
- Ultrasonic washers
Automated endoscope reprocessors (AERs)
- Single basin automated endoscopic reprocessors
- Double-basin automated endoscopic reprocessors
- Based on modality
- Stand-alone endoscopic reprocessors
- Benchtop endoscopic reprocessors
- Rest of Europe
Middle East and Africa
Key players identified for the endoscope reprocessing device market include but are not limited to:
STERIS Plc., Cilag GmbH International, Soluscope, ENDO-TECHNIK W.Griesat GmbH, Getinge AB, Wassenburg Medical B.V., Steelco S.p.A., MEDIVATORS Inc. (Cantel Medical Corp.), Johnson & Johnson, and Minntech Corp.
This report offers the following:
- An overview of the global markets for endoscope reprocessing devices
- Market trends assessment for the period 2013-2023, with historical information for 2013, 2014, and 2015, and projections through 2023, with respective CAGRs during 2016-2023
- Qualitative assessment tools such as market drivers, challenges, and opportunities
- Market competition scrutiny tools such as market share analysis, fractal map assessment, and Porter’s Five Forces model
- Focus on each level of market segmentation based on product approvals, launches, and current and anticipated market dynamics.
- A general overview of the industry structure
- Company profiles highlight key information about the major players operating in the endoscope reprocessing device market.